Treating relapsed myeloma Around 5,700 people are diagnosed with myeloma in the UK each year. As there is no cure…
Establishing a resource for chronic lymphocytic leukaemia researchers
'Biobanks give researchers access to biological material and clinical data on a scale that individual researchers would not be able…
Interview with Diana Jupp, CEO, Pancreatic Cancer UK
'Why did Pancreatic Cancer UK want to become NCRI partners? For decades, too little progress has been made in pancreatic…
Getting to know: Pancreatic Cancer UK
'Pancreatic Cancer UK was founded in 2003 by Sue Ballard, whose husband, John, died of pancreatic cancer. She was determined…
Accurate detection of prostate cancer and the crucial role of patient involvement
'The Prostagram trial investigated the use of MRI scans to detect prostate cancer. At present, there is no nationally approved…
Could drug treatment combined with targeted radiotherapy improve brain mets prognosis?
'Patients with brain metastases are an underserved population Brain metastases occur in 20-40% of all patients with cancer. Brain metastases…
Working with patients and carers to answer questions in a rare cancer
'Upper tract urothelial cancer is a rare type of cancer that starts in the lining of the urinary tract and…
Improving survival in women with poor-prognosis ovarian cancer
'Around 7,500 women are diagnosed with ovarian cancer in the UK each year. This makes ovarian cancer the 6th most…
Two trials for brain metastases developed following Brain Metastases Workshop
'Brain metastases occur when cancer cells spread from their original site to the brain. Any cancer can spread to the…
Trials & tribulations in oesophageal cancer
'Christopher M. Jones & Tom Crosby, on behalf of the National Cancer Research InstituteĀ Upper Gastrointestinal Oesophagogastric Subgroup We have a…
Quick and efficient testing of prostate cancer treatments, changing trial design and clinical practice
'Lack of treatments and evidence As recently as ten years ago, despite many new drugs being approved for use in…
Reducing the number of prostate biopsies by improving diagnosis
'Addressing problems with prostate cancer diagnosis To diagnose prostate cancer, PSA (prostate specific antigen) levels in the blood are used…